Dopamine system dysregulation in major depressive disorders

P Belujon, AA Grace - International Journal of …, 2017 - academic.oup.com
Anhedonia is considered a core feature of major depressive disorder, and the dopamine
system plays a pivotal role in the hedonic deficits described in this disorder. Dopaminergic …

Reinforcement learning in depression: A review of computational research

C Chen, T Takahashi, S Nakagawa, T Inoue… - … & Biobehavioral Reviews, 2015 - Elsevier
Despite being considered primarily a mood disorder, major depressive disorder (MDD) is
characterized by cognitive and decision making deficits. Recent research has employed …

[PDF][PDF] Cognitive therapy for depression

JE Young, JL Rygh, AD Weinberger… - Clinical handbook of …, 2008 - ndl.ethernet.edu.et
One of the most important developments in psychosocial approaches to emotional problems
has been the success of cognitive therapy for depression. Evidence for the powerful efficacy …

Evidence-based pharmacotherapy of treatment-resistant unipolar depression

M Dold, S Kasper - International journal of psychiatry in clinical …, 2017 - Taylor & Francis
Abstract Treatment resistance to the antidepressive pharmacotherapy represents one of the
most important clinical challenges in the pharmacological management of unipolar …

[HTML][HTML] The treatment of depression—Searching for new ideas

K Stachowicz, M Sowa-Kućma - Frontiers in Pharmacology, 2022 - frontiersin.org
Depression is a severe mental health problem that affects people regardless of social status
or education, is associated with changes in mood and behavior, and can result in a suicide …

Vagus nerve stimulation (VNS) and other augmentation strategies for therapy-resistant depression (TRD): review of the evidence and clinical advice for use

HHO Müller, S Moeller, C Lücke, AP Lam… - Frontiers in …, 2018 - frontiersin.org
In addition to electroconvulsive therapy (ECT) and repetitive transcranial magnetic
stimulation (rTMS), vagus nerve stimulation (VNS) is one of the approved neurostimulation …

Rodent models of treatment-resistant depression

BJ Caldarone, V Zachariou, SL King - European journal of pharmacology, 2015 - Elsevier
Major depression is a prevalent and debilitating disorder and a substantial proportion of
patients fail to reach remission following standard antidepressant pharmacological …

Challenging treatment-resistant major depressive disorder: a roadmap for improved therapeutics

RT de Sousa, MV Zanetti, AR Brunoni… - Current …, 2015 - ingentaconnect.com
Major depressive disorder (MDD) is associated with a significant burden and costs to the
society. As remission of depressive symptoms is achieved in only one-third of the MDD …

A meta-analysis of memantine for depression

T Kishi, S Matsunaga, N Iwata - Journal of Alzheimer's …, 2017 - content.iospress.com
We conducted a systematic review and meta-analysis on whether memantine was beneficial
for the treatment of depressive symptoms in major depressive disorder (MDD) and bipolar …

Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant …

P Olgiati, A Serretti, D Souery, M Dold, S Kasper… - Journal of affective …, 2018 - Elsevier
Background Initial improvement in the first weeks of antidepressant (AD) treatment is a
useful early predictor of complete AD response. We performed a meta-analysis of AD …